English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2189]
News [5845]
Articles [114]
Editorials [31]
Conferences [184]
elearning [22]
Scientists report promising results from first-in-human clinical trial of switchable CAR-T (CLBR001 + SWI019), a next-generation universal CAR-T platform designed to enhance the versatility and safety of cell therapies
Scientists report promising results from first-in-human clinical trial of switchable CAR-T (CLBR001 + SWI019), a...
Cancer progress report highlights innovative cancer research that improves, extends, and saves lives
Cancer progress report highlights innovative cancer research that improves, extends, and saves lives
Scientists identify key biomarkers that reliably predict response to immune checkpoint inhibitor therapy for melanoma
Scientists identify key biomarkers that reliably predict response to immune checkpoint inhibitor therapy for...
Stress granules may drive obesity-associated pancreatic cancer
Stress granules may drive obesity-associated pancreatic cancer
Scientists suggest near-infrared-triggered nanozyme-mediated synergistic cascade tumor therapy
Scientists suggest near-infrared-triggered nanozyme-mediated synergistic cascade tumor therapy
Cancer mortality rates correlate to geography as well as known behavioural risk factors
Cancer mortality rates correlate to geography as well as known behavioural risk factors
AI helps detect pancreatic cancer
AI helps detect pancreatic cancer
ESMO 2022: ADAURA trial results provide new hope for patients with early-stage non-small cell lung cancer
ESMO 2022: ADAURA trial results provide new hope for patients with early-stage non-small cell lung cancer
ESMO 2022: A new era of early cancer detection with blood test may change cancer screening paradigms
ESMO 2022: A new era of early cancer detection with blood test may change cancer screening paradigms
ESMO 2022: Nivolumab ipilimumab combo does not improve DFS for RCC after nephrectomy
ESMO 2022: Nivolumab ipilimumab combo does not improve DFS for RCC after nephrectomy
<1...99100101102103...585>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top